☆ 4.6 Article

Unraveling the Role of Hepatic PGC1a in Breast Cancer Invasion: A New Target for Therapeutic Intervention?

CELLS (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Biochemistry & Molecular Biology

Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0

Antonella Zannetti

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Oncology

The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes

Sayali S. Onkar et al.

Summary: Breast cancer is a diverse disease with different subtypes, and recent advances have provided new insights into the complex interactions between tumor and immune cells. While immunotherapy has shown limited promise for breast cancer, this review aims to identify opportunities for tailored immunotherapy agents based on the specific features of each breast cancer subtype.

CANCER DISCOVERY (2023)

Add to Collection

Review Pharmacology & Pharmacy

Alcohol and breast cancer

Beata Starek-Swiechowicz et al.

Summary: Breast cancer is a leading cause of death in women worldwide, and alcohol plays a significant role in the development of tumors. This paper discusses the metabolism of alcohol and the mechanisms behind mammary tumorigenesis caused by alcohol. It presents numerous signaling pathways involved in neoplastic transformation following alcohol consumption in women and describes primary and secondary prevention, phytochemicals, synthetic chemicals, specific enzyme inhibitors, and selective receptor modulators.

PHARMACOLOGICAL REPORTS (2023)

Add to Collection

Review Obstetrics & Gynecology

Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023

Melitta M. Kopke et al.

Summary: This article reviews the rapid evolution of breast carcinoma therapy in recent years, particularly the use of biomarkers in guiding (neo)adjuvant endocrine therapy and chemotherapy for early breast cancer.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis

Alessandro Mantovani et al.

Summary: This meta-analysis confirms a significant association between non-alcoholic fatty liver disease (NAFLD) and increased risk of chronic kidney disease (CKD). It also suggests that the severity of NAFLD may influence the risk of CKD.

GUT (2022)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies

Alessandro Mantovani et al.

Summary: This meta-analysis found that NAFLD was significantly associated with an increased risk of developing gastrointestinal cancers (esophagus, stomach, pancreas, or colorectal cancers) by nearly 1.5-fold to 2-fold, as well as an increased risk of developing lung, breast, gynecological, or urinary system cancers by approximately 1.2-fold to 1.5-fold. These risks were independent of age, sex, smoking, obesity, diabetes, or other potential confounders.

GUT (2022)

Add to Collection

Review Endocrinology & Metabolism

Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation

Sandra C. Naaman et al.

Summary: Obesity is associated with an increased risk of postmenopausal, hormone receptor-positive breast cancer. Factors such as altered adipokine balance and chronic inflammation contribute to tumorigenesis.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Review Endocrinology & Metabolism

Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss

Sjaak Pouwels et al.

Summary: Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public health. NAFLD is closely associated with metabolic disorders and can range from mild forms to severe forms with potential liver failure. Advanced fibrosis is a major predictor of morbidity and liver-related mortality. Diagnosis of NAFLD is established through liver biopsy and treatment options include weight loss, dietary modification, and addressing underlying metabolic syndrome.

BMC ENDOCRINE DISORDERS (2022)

Add to Collection

Review Endocrinology & Metabolism

Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones

K. Pafili et al.

Summary: The prevalence of non-alcoholic fatty liver disease (NAFLD) varies among different stages of the female lifespan. This review summarizes the current evidence on the association between NAFLD and circulating sex hormones and explores the pathogenesis of NAFLD in relation to hormonal changes during reproductive, post-reproductive, and beyond. It also examines the effects of hormone therapies on NAFLD in women on menopausal hormone treatment or endocrine therapy after breast cancer. The findings suggest that fluctuations in estrogen levels, relative androgen excess, and age-related reduction in sex hormone-binding globulin are associated with increased NAFLD risk. Additionally, changes in body composition and insulin resistance during the peri-menopausal period may contribute to the increased risk of NAFLD. Further research is needed to identify subgroups at highest risk for NAFLD development and progression and to determine the role of hormone therapies, such as menopausal hormone treatment.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Add to Collection

Article Biochemistry & Molecular Biology

DDX17 protects hepatocytes against oleic acid/palmitic acid-induced lipid accumulation

Xiaoyi Zhang et al.

Summary: DDX17 overexpression inhibits lipid accumulation in hepatic cells induced by oleic acid/palmitic acid, possibly through inhibition of de novo fatty acid synthesis.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Add to Collection

Review Oncology

Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis

James A. Thomas et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is associated with hepatocellular carcinoma (HCC) and extrahepatic cancer. The incidence rate of HCC is higher in patients with advanced liver fibrosis or cirrhosis, while the incidence rate of extrahepatic cancers is even higher. These findings emphasize the importance of prevention and early detection of cancer in adults with NAFLD.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Editorial Material Genetics & Heredity

Breast Cancer Genetics: Diagnostics and Treatment

Carmen Criscitiello et al.

GENES (2022)

Add to Collection

Review Endocrinology & Metabolism

Nonalcoholic fatty liver disease and diabetes

Maria Irene Bellini et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease worldwide and is closely associated with insulin resistance and diabetes. Treatment for NAFLD depends on the severity of the disease, including abstinence from alcohol, dietary changes, and reduction of risk factors, as well as procedures like weight loss surgery to improve liver condition.

WORLD JOURNAL OF DIABETES (2022)

Add to Collection

Article Oncology

Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer

Elizabeth A. Wellberg et al.

Summary: Preventing weight gain after ovariectomy can decrease the development and growth of obesity-associated breast tumors, reduce visceral fat accumulation and insulin resistance. It also decreases the levels of tumor-promoting growth factors and inflammatory cytokines, and reduces the expression of tumor-promoting factors in mammary adipose tissue.

BREAST CANCER RESEARCH (2022)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals

Alessandro Mantovani et al.

Summary: This meta-analysis shows that patients with NAFLD have a significantly increased risk of developing diabetes, and this risk rises with the severity of NAFLD. The risk is independent of age, sex, adiposity measures, and other metabolic risk factors.

GUT (2021)

Add to Collection

Article Biochemistry & Molecular Biology

TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues

Aron Bartha et al.

Summary: This study established an integrated database of gene expression data from tumor and metastatic tissues, identifying potential therapeutic targets for different cancer types. The online platform allows real-time mining and analysis of the database, providing valuable insights for cancer research and treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis

Alessandro Mantovani et al.

Summary: Studies have shown a significant association between non-alcoholic fatty liver disease (NAFLD) and increased risk of cardiovascular disease (CVD) incidence. The risk of fatal or non-fatal CVD events is moderately increased with NAFLD, and this risk escalates with the severity of NAFLD, particularly with higher fibrosis stages. These findings suggest that NAFLD may be an independent risk factor for CVD morbidity and mortality.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Oncology

PGC-1α activates SIRT3 to modulate cell proliferation and glycolytic metabolism in breast cancer

Yan Zu et al.

Summary: In this study, lower expression levels of PGC-1 alpha and SIRT3 were observed in breast cancer patients. Overexpression of PGC-1 alpha or SIRT3 significantly promoted apoptosis and inhibited proliferation in breast cancer cells. Furthermore, both PGC-1 alpha and SIRT3 were found to induce inhibition of glycolysis metabolism, with SIRT3 expression positively regulated by PGC-1 alpha.

NEOPLASMA (2021)

Add to Collection

Article Oncology

Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study

Jin Hyun Park et al.

CLINICAL BREAST CANCER (2020)

Add to Collection

Review Gastroenterology & Hepatology

Update on NAFLD genetics: From new variants to the clinic

Eric Trepo et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis

Xiaoqin Wu et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Nutrition & Dietetics

Srebp-1c/Fgf21/Pgc-1α Axis Regulated by Leptin Signaling in Adipocytes-Possible Mechanism of Caloric Restriction-Associated Metabolic Remodeling of White Adipose Tissue

Masaki Kobayashi et al.

NUTRIENTS (2020)

Add to Collection

Article Oncology

The impact of pre-existed and SERM-induced non-alcoholic fatty liver disease on breast cancer survival: a meta-analysis

Changjun Wang et al.

JOURNAL OF CANCER (2020)

Add to Collection

Article Gastroenterology & Hepatology

Macrophage-Specific Hypoxia-Inducible Factor-1α Contributes to Impaired Autophagic Flux in Nonalcoholic Steatohepatitis

Xiaojing Wang et al.

HEPATOLOGY (2019)

Add to Collection

Review Oncology

In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ

Ethan J. Brock et al.

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2019)

Add to Collection

Article Oncology

Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study

Jung Il Lee et al.

ONCOLOGIST (2019)

Add to Collection

Article Medicine, General & Internal

Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery

Young-Sun Lee et al.

MEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR- and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet

Fan Zheng et al.

LIPIDS IN HEALTH AND DISEASE (2019)

Add to Collection

Article Oncology

Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer

Young Kyuen Im et al.

CANCER RESEARCH (2018)

Add to Collection

Article Gastroenterology & Hepatology

Association between non-alcoholic fatty liver disease and cancer incidence rate

Gi-Ae Kim et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Protective Effect of Aqueous Extract from the Leaves of Justicia tranquebariesis against Thioacetamide-Induced Oxidative Stress and Hepatic Fibrosis in Rats

Kumeshini Sukalingam et al.

ANTIOXIDANTS (2018)

Add to Collection

Article Oncology

The association between metabolic health, obesity phenotype and the risk of breast cancer

Yong-Moon Mark Park et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Add to Collection

Article Gastroenterology & Hepatology

O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress

Weiqi Xu et al.

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Oncology

Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients

Seokwon Lee et al.

TUMORI (2017)

Add to Collection

Article Oncology

Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients

Seokwon Lee et al.

TUMORI (2017)

Add to Collection

Article Oncology

Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women

Geoffrey C. Kabat et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Add to Collection

Article Cell Biology

PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs

Sylvia Andrzejewski et al.

CELL METABOLISM (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Solanum trilobatum L. Ameliorate Thioacetamide-Induced Oxidative Stress and Hepatic Damage in Albino Rats

Kumar Ganesan et al.

ANTIOXIDANTS (2017)

Add to Collection

Article Medicine, Research & Experimental

PGC-1 alpha interacts with microRNA-217 to functionally regulate breast cancer cell proliferation

Shaohui Zhang et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes

Kfir Sharabi et al.

CELL (2017)

Add to Collection

Review Biochemistry & Molecular Biology

The molecular mechanisms between metabolic syndrome and breast cancer

Yi Chen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Add to Collection

Article Cell Biology

Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells

Alexandra M. Hetherington et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes

Zobair M. Younossi et al.

HEPATOLOGY (2016)

Add to Collection

Article Cell Biology

MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression

C. Lou et al.

CELL DEATH & DISEASE (2016)

Add to Collection

Article Oncology

Prognostic value of plasma levels of HIF-1β and PGC-1β in breast cancer

Feng-Feng Cai et al.

ONCOTARGET (2016)

Add to Collection

Article Cell Biology

The PGC-1α/ERRα Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer

Etienne Audet-Walsh et al.

CELL REPORTS (2016)

Add to Collection

Article Endocrinology & Metabolism

Quantitative assessment of adipocyte differentiation in cell culture

Nils A. Kraus et al.

ADIPOCYTE (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Stress of endoplasmic reticulum modulates differentiation and lipogenesis of human adipocytes

Michal Koc et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Add to Collection

Article Gastroenterology & Hepatology

Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo

Min-Jung Park et al.

JOURNAL OF HEPATOLOGY (2014)

Add to Collection

Article Cell Biology

PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

Valerie S. LeBleu et al.

NATURE CELL BIOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays

Camilo Guzman et al.

PLOS ONE (2014)

Add to Collection

Article Endocrinology & Metabolism

Weight Loss Improves the Adipogenic Capacity of Human Preadipocytes and Modulates Their Secretory Profile

Lenka Rossmeislova et al.

DIABETES (2013)

Add to Collection

Review Biochemistry & Molecular Biology

The PGC-1/ERR signaling axis in cancer

G. Deblois et al.

ONCOGENE (2013)

Add to Collection

Review Oncology

Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond

Genevieve Deblois et al.

NATURE REVIEWS CANCER (2013)

Add to Collection

Article Oncology

PGC-1α supports glutamine metabolism in breast cancer

Shawn McGuirk et al.

CANCER & METABOLISM (2013)

Add to Collection

Article Oncology

PGC-1α Promotes the Growth of ErbB2/Neu-Induced Mammary Tumors by Regulating Nutrient Supply

Eva Klimcakova et al.

CANCER RESEARCH (2012)

Add to Collection

Review Cell Biology

The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer

Geoffrey D. Girnun

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)

Add to Collection

Article Oncology

Metabolic syndrome and the risk of breast cancer in postmenopausal women

V. Rosato et al.

ANNALS OF ONCOLOGY (2011)

Add to Collection

Article Medicine, Research & Experimental

Cysteine aggravates palmitate-induced cell death in hepatocytes

Xiaobing Dou et al.

LIFE SCIENCES (2011)

Add to Collection

Article Pharmacology & Pharmacy

Current and Future Development of Estrogen Receptor Ligands: Applications in Estrogen-Related Cancers

Alessandro Bolli et al.

RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2011)

Add to Collection

Article Oncology

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Balazs Gyoerffy et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Add to Collection

Article Gastroenterology & Hepatology

Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis

Yuko Akazawa et al.

JOURNAL OF HEPATOLOGY (2010)

Add to Collection

Article Gastroenterology & Hepatology

Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

Matteo Ricchi et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)

Add to Collection

Article Multidisciplinary Sciences

HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α

Zoltan Arany et al.

NATURE (2008)

Add to Collection

Article Biochemistry & Molecular Biology

A human hepatocellular in vitro model to investigate steatosis

Maria Jose Gomez-Lechon et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2007)

Add to Collection

Article Oncology

A case-control study of non-alcoholic fatty liver disease in breast cancer

Ahmet Bilici et al.

MEDICAL ONCOLOGY (2007)

Add to Collection

Article Biochemistry & Molecular Biology

Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis

H Malhi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Add to Collection

Article Oncology

Estrogen-related receptor a in human breast carcinoma as a potent prognostic factor

T Suzuki et al.

CANCER RESEARCH (2004)

Add to Collection

Article Multidisciplinary Sciences

Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

JC Yoon et al.

NATURE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.